DOCSLIB.ORG

Epigenetics: X Inactivation by Titration

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Epigenetics: X Inactivation by Titration RESEARCH HIGHLIGHTS Nature Reviews Genetics | AOP, published online 2 July 2013; doi:10.1038/nrg3538 Photodisc/Getty differentiation in female cells, CTCF binding at this site is depleted in the future inactive X chromosome. Furthermore, CTCF transgene studies indicated that CTCF was a direct Xist repressor. Sun et al. were then able to show a link between Jpx and CTCF: Jpx EPIGENETICS overexpression relieved the effects of CTCF overexpression. Furthermore, X inactivation by titration they showed direct binding of Jpx to CTCF in vivo. Finally, ChIP confirmed X-chromosome inactivation (XCI) Sun et al. postulated that the that when CTCF was overexpressed, in mammals compensates for the X-encoded lncRNA Jpx, which is known the binding of CTCF to P2 was imbalance in X chromosome number to activate the transcription of Xist, is increased, and Xist upregulation between females (XX) and males (XY). a good candidate for an X-encoded was compromised. However, when How the number of X chromosomes is numerator. In support of this hypothesis, Jpx alone was overexpressed, counted by the cell is a long-standing transgene experiments in mouse CTCF binding to Xist was reduced problem. A recent study has implicated embryonic stem cells (ESCs) showed approximately by half. an X-encoded long non-coding that Xist displays a dosage-dependent The authors’ data point towards a RNA (lncRNA) in X-chromosome response to Jpx expression, so Xist model in which, in order to initiate XCI, counting that titrates an autosomal expression is switched on only when the Jpx is activated and titrates repressive transcription factor away from the X levels of Jpx are high enough. CTCF away from the Xist promoter chromosome to inactivate it. The authors then chose to investigate through competitive binding; this A recent study Mammalian XCI is known to occur CTCF as a potential autosomal is the first time that such a function has implicated when the X to autosome ratio (X/A) is regulator of XCI initiation — that is, as has been reported for an lncRNA. ≥1, leading to the expression of inactive an autosome-encoded denominator The allele-specific nature of these an X-encoded X specific transcript (Xist), which is an of the X/A ratio — as putative binding interactions suggests that further long non- lncRNA that silences the X chromosome. sites for the CTCF transcription factor regulatory factors are yet to be found. coding RNA in However, a full understanding of had previously been identified in the Hannah Stower how the cell calculates the X/A ratio Xist promoter. They used chromatin X-chromosome through X-encoded numerators and immunoprecipitation (ChIP) to show ORIGINAL RESEARCH PAPER Sun, S. et al. Jpx counting autosomally encoded denominators has that CTCF binds to the promoter site RNA activates Xist by evicting CTCF. Cell 153, been elusive. P2 in ESCs prior to XCI. However, on 1537–1551 (2013) NATURE REVIEWS | GENETICS VOLUME 14 | AUGUST 2013 © 2013 Macmillan Publishers Limited. All rights reserved.
Load more

Recommended publications
  • Revealing the Mechanism of Xist-Mediated Silencing
    Revealing the Mechanism of Xist-mediated Silencing Thesis by Chun-Kan Chen In Partial Fulfillment of the Requirements for the degree of Doctor of Philosophy CALIFORNIA INSTITUTE OF TECHNOLOGY Pasadena, California 2018 Defended November 1, 2017 ii 2017 Chun-Kan Chen ORCID: 0000-0002-1194-9137 iii ACKNOWLEDGEMENTS First of all, I’d like to thank my great mentor, Dr. Mitch Guttman (California Institute of Technology, Pasadena, CA), who led me to become an independent researcher and gave me valuable advice that guided me to accomplish this thesis. He has always been supportive of my future plans and career goals. I really enjoyed every discussion we have had. We often generated some interesting ideas for projects during our discussions. I would also like to send my thanks to my lab mates, Amy Chow, Mario Blanco, and Erik Aznauryan, who helped me with many experiments to move the project forward. I’d like to acknowledge Dr. Kathrin Plath (University of California, Los Angeles, Los Angeles, CA) for the collaboration and his critical comments on this project. Also, I want to thank Jesse Engreitz and Patrick McDonel, who provided helpful comments and suggestions to the project. I want to thank my parents, brother, and parents-in-law who provided both instrumental and emotional support to assist me in completing my Ph.D. degree. I also want to thank my friends, Lily Chen, Pei-Ying Lin, Tzu-Yao Wang, and Wei Li, for giving me valuable social support during my years in graduate school. Last but not least, I would like to send my special thanks to my wife, Christine Juang, who has always been supportive.
    [Show full text]
  • Association of BRCA1 with the Inactive X Chromosome and XIST RNA
    FirstCite Published online e-publishing Association of BRCA1 with the inactive X chromosome and XIST RNA Shridar Ganesan1, Daniel P. Silver1, Ronny Drapkin1, Roger Greenberg1, Jean Feunteun2 and David M. Livingston1* 1The Dana-Farber Cancer Institute and Harvard Medical School, 1 Jimmy Fund Way, Boston, MA 02115, USA 2Laboratoire de Genetique et Transfert de Gene, Institut Gustav-Roussy, Villejuif 94805, France Breast cancer, early onset 1 (BRCA1) encodes a nuclear protein that participates in breast and ovarian cancer suppression. The molecular basis for the gender and tissue specificity of the BRCA1 cancer syn- drome is unknown. Recently, we observed that a fraction of BRCA1 in female cells is localized on the inactive X chromosome (Xi). Chromatin immunoprecipitation (ChIP) experiments have demonstrated that BRCA1 physically associates with Xi-specific transcript (XIST) RNA, a non-coding RNA known to coat Xi and to participate in the initiation of its inactivation during early embryogenesis. Cells lacking wild- type BRCA1 show abnormalities in Xi, including lack of proper XIST RNA localization. Reintroduction of wild-type, but not mutant, BRCA1 can correct this defect in XIST localization in these cells. Depletion of BRCA1 in female diploid cells led to a defect in proper XIST localization on Xi and in the development of normal Xi heterchromatic superstructure. Moreover, depletion of BRCA1 led to an increased likelihood of re-expression of a green fluorescent protein (GFP) reporter gene embedded on Xi. Taken together, these findings are consistent with a model in which BRCA1 function contributes to the maintenance of proper Xi heterochromatin superstructure. Although the data imply a novel gender-specific consequence of BRCA1 loss, the relevance of the BRCA1/Xi function to the tumour suppressor activity of BRCA1 remains unclear and needs to be tested.
    [Show full text]
  • Dynamics of Gene Silencing During X Inactivation Using Allele-Specific RNA-Seq Hendrik Marks1*, Hindrik H
    Marks et al. Genome Biology (2015) 16:149 DOI 10.1186/s13059-015-0698-x RESEARCH Open Access Dynamics of gene silencing during X inactivation using allele-specific RNA-seq Hendrik Marks1*, Hindrik H. D. Kerstens1, Tahsin Stefan Barakat3, Erik Splinter4, René A. M. Dirks1, Guido van Mierlo1, Onkar Joshi1, Shuang-Yin Wang1, Tomas Babak5, Cornelis A. Albers2, Tüzer Kalkan6, Austin Smith6, Alice Jouneau7, Wouter de Laat4, Joost Gribnau3 and Hendrik G. Stunnenberg1* Abstract Background: During early embryonic development, one of the two X chromosomes in mammalian female cells is inactivated to compensate for a potential imbalance in transcript levels with male cells, which contain a single X chromosome. Here, we use mouse female embryonic stem cells (ESCs) with non-random X chromosome inactivation (XCI) and polymorphic X chromosomes to study the dynamics of gene silencing over the inactive X chromosome by high-resolution allele-specific RNA-seq. Results: Induction of XCI by differentiation of female ESCs shows that genes proximal to the X-inactivation center are silenced earlier than distal genes, while lowly expressed genes show faster XCI dynamics than highly expressed genes. The active X chromosome shows a minor but significant increase in gene activity during differentiation, resulting in complete dosage compensation in differentiated cell types. Genes escaping XCI show little or no silencing during early propagation of XCI. Allele-specific RNA-seq of neural progenitor cells generated from the female ESCs identifies three regions distal to the X-inactivation center that escape XCI. These regions, which stably escape during propagation and maintenance of XCI, coincide with topologically associating domains (TADs) as present in the female ESCs.
    [Show full text]
  • Lncrna Jpx Induces Xist Expression in Mice Using Both Trans and Cis Mechanisms
    RESEARCH ARTICLE LncRNA Jpx induces Xist expression in mice using both trans and cis mechanisms Sarah Carmona, Benjamin Lin, Tristan Chou, Katti Arroyo, Sha Sun* Department of Developmental and Cell Biology, Ayala School of Biological Sciences, University of California, Irvine, Irvine, CA, United States of America * [email protected] a1111111111 a1111111111 Abstract a1111111111 a1111111111 Mammalian X chromosome dosage compensation balances X-linked gene products a1111111111 between sexes and is coordinated by the long noncoding RNA (lncRNA) Xist. Multiple cis and trans-acting factors modulate Xist expression; however, the primary competence factor responsible for activating Xist remains a subject of dispute. The lncRNA Jpx is a proposed competence factor, yet it remains unknown if Jpx is sufficient to activate Xist expression in OPEN ACCESS mice. Here, we utilize a novel transgenic mouse system to demonstrate a dose-dependent relationship between Jpx copy number and ensuing Jpx and Xist expression. By localizing Citation: Carmona S, Lin B, Chou T, Arroyo K, Sun S (2018) LncRNA Jpx induces Xist expression in transcripts of Jpx and Xist using RNA Fluorescence in situ Hybridization (FISH) in mouse mice using both trans and cis mechanisms. PLoS embryonic cells, we provide evidence of Jpx acting in both trans and cis to activate Xist. Our Genet 14(5): e1007378. https://doi.org/10.1371/ data contribute functional and mechanistic insight for lncRNA activity in mice, and argue that journal.pgen.1007378 Jpx is a competence factor for Xist activation in vivo. Editor: Gregory S. Barsh, Stanford University School of Medicine, UNITED STATES Received: November 20, 2017 Accepted: April 24, 2018 Author summary Published: May 7, 2018 Long noncoding RNA (lncRNA) have been identified in all eukaryotes but mechanisms Copyright: © 2018 Carmona et al.
    [Show full text]
  • Long Non‑Coding Rnas XIST and MALAT1 Hijack the PD‑L1 Regulatory Signaling Pathway in Breast Cancer Subtypes
    ONCOLOGY LETTERS 22: 593, 2021 Long non‑coding RNAs XIST and MALAT1 hijack the PD‑L1 regulatory signaling pathway in breast cancer subtypes AMANY SAMIR1, REDA ABDEL TAWAB2 and HEND M. EL TAYEBI1 1Molecular Pharmacology Research Group, Department of Pharmacology and Toxicology, German University in Cairo, Cairo 11835; 2Department of General Surgery, Ain Shams University, Cairo 11772, Egypt Received July 18, 2020; Accepted January 14, 2021 DOI: 10.3892/ol.2021.12854 Abstract. Long non‑coding RNAs (lncRNAs) have attracted presence of lncRNAs. Therefore, the results of the present widespread attention as potential biological and patho‑ study indicated that although miR‑182‑5p exhibited an onco‑ logical regulators. lncRNAs are involved in several biological genic effect, XIST exerted a dominant effect on the regulation processes in cancer. Triple negative breast cancer (TNBC) is of the PD‑L1 signaling pathway via the inhibition of the onco‑ characterized by strong heterogeneity and aggressiveness. At genic function of MALAT1. present, the implication of microRNAs (miRs) and lncRNAs in immunotherapy has been poorly studied. Nevertheless, Introduction the blockade of immune checkpoints, particularly that of the programmed cell‑death protein‑1/programmed cell‑death In the context of tumor biology, the six hallmarks of cancer ligand‑1 (PD‑L1) axis, is considered as a principle approach in have been proposed to be associated with progressively breast cancer (BC) therapy. The present study aimed to inves‑ growing tumors and to be responsible for the complexity of tigate the interaction between immune‑modulatory upstream neoplastic diseases, and these are limitless replicative poten‑ signaling pathways of the PD‑L1 transcript that could enhance tial, evading apoptosis, self‑sufficiency in growth signals, personalized targeted therapy.
    [Show full text]
  • Repetitive Elements in Humans
    International Journal of Molecular Sciences Review Repetitive Elements in Humans Thomas Liehr Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Am Klinikum 1, D-07747 Jena, Germany; [email protected] Abstract: Repetitive DNA in humans is still widely considered to be meaningless, and variations within this part of the genome are generally considered to be harmless to the carrier. In contrast, for euchromatic variation, one becomes more careful in classifying inter-individual differences as meaningless and rather tends to see them as possible influencers of the so-called ‘genetic background’, being able to at least potentially influence disease susceptibilities. Here, the known ‘bad boys’ among repetitive DNAs are reviewed. Variable numbers of tandem repeats (VNTRs = micro- and minisatellites), small-scale repetitive elements (SSREs) and even chromosomal heteromorphisms (CHs) may therefore have direct or indirect influences on human diseases and susceptibilities. Summarizing this specific aspect here for the first time should contribute to stimulating more research on human repetitive DNA. It should also become clear that these kinds of studies must be done at all available levels of resolution, i.e., from the base pair to chromosomal level and, importantly, the epigenetic level, as well. Keywords: variable numbers of tandem repeats (VNTRs); microsatellites; minisatellites; small-scale repetitive elements (SSREs); chromosomal heteromorphisms (CHs); higher-order repeat (HOR); retroviral DNA 1. Introduction Citation: Liehr, T. Repetitive In humans, like in other higher species, the genome of one individual never looks 100% Elements in Humans. Int. J. Mol. Sci. alike to another one [1], even among those of the same gender or between monozygotic 2021, 22, 2072.
    [Show full text]
  • Non-Coding RNA: X-Chromosome Inactivation Unravelled
    RESEARCH HIGHLIGHTS Nature Reviews Molecular Cell Biology | AOP, published online 8 May 2015; doi:10.1038/nrm3998 NON-CODING RNA X-chromosome inactivation unravelled The long non-coding RNA (lncRNA) specific and reproducible set of ten suggesting that SAFA acts to localize Xist (X inactive-specific transcript) is proteins that directly interact with Xist to genomic DNA. Depleting required for the transcriptional silenc- Xist. Of these proteins, knocking Xist binds to SHARP led to the retention of Pol II ing of one X chromosome in each cell, down the genes encoding scaffold SHARP to at Xist-coated X chromosomes, in a process known as X-chromosome attachment factor A (SAFA; also recruit SMRT indicating that SHARP might be inactivation (XCI) that occurs during known as HNRNPU), SMRT- and required for initiating transcriptional mammalian female development. HDAC1-associated repressor protein and activate silencing following Xist localization, Owing to technical limitations, little (SHARP; also known as SPEN or HDAC3 … possibly by recruiting the transcrip- is known about the mechanism of MSX2-interacting protein) and resulting in tional co-repressors SMRT and transcriptional silencing during XCI. lamin-B receptor (LBR) largely abol- HDAC3. Indeed, depleting SMRT McHugh et al. now describe using ished the silencing of XCI‑affected gene silencing or HDAC3 (but not other HDACs) RNA antisense purification followed genes in the male ES cells as well as in abrogated Xist-dependent gene by quantitative mass spectrometry differentiating female ES cells. These silencing. Another feature of XCI (RAP–MS) — a novel approach for three proteins are therefore required is the recruitment of the Polycomb identifying proteins that directly for Xist-mediated gene silencing.
    [Show full text]
  • Agonists Regulate the Expression of Stemness and Differentiation Genes in Brain Tumour Stem Cells
    British Journal of Cancer (2012) 106, 1702–1712 & 2012 Cancer Research UK All rights reserved 0007 – 0920/12 www.bjcancer.com PPARg agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells E Pestereva1, S Kanakasabai1 and JJ Bright*,1,2 1 Neuroscience Research Laboratory, Methodist Research Institute, Indiana University Health, 1800 North Capitol Avenue, Noyes Building E504C, 2 Indianapolis, IN 46202, USA; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA BACKGROUND: Brain tumour stem cells (BTSCs) are a small population of cancer cells that exhibit self-renewal, multi-drug resistance, and recurrence properties. We have shown earlier that peroxisome proliferator-activated receptor gamma (PPARg) agonists inhibit the expansion of BTSCs in T98G and U87MG glioma. In this study, we analysed the influence of PPARg agonists on the expression of stemness and differentiation genes in BTSCs. METHODS: The BTSCs were isolated from T98G and DB29 glioma cells, and cultured in neurobasal medium with epidermal growth factor þ basic fibroblast growth factor. Proliferation was measured by WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2 H-5- tetrazolio]-1,3-benzene disulphonate) and 3H thymidine uptake assays, and gene expression was analysed by quantitative reverse– transcription PCR and Taqman array. The expression of CD133, SRY box 2, and nanog homeobox (Nanog) was also evaluated by western blotting, immunostaining, and flow cytometry. 12,14 RESULTS: We found that PPARg agonists, ciglitazone and 15-deoxy-D -ProstaglandinJ2, inhibited cell viability and proliferation of þ T98G- and DB29-BTSCs. The PPARg agonists reduced the expansion of CD133 BTSCs and altered the expression of stemness and differentiation genes.
    [Show full text]
  • Reprogramming Capacity of Nanog Is Functionally Conserved in Vertebrates and Resides in a Unique Homeodomain Thorold W
    Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain Thorold W. Theunissen, Yael Costa, Aliaksandra Radzisheuskaya, A., Anouk L. van Oosten, Fabrice Lavial, Bertrand Pain, L. Filipe C. Castro Castro, José C. R. Silva, J. C. R. To cite this version: Thorold W. Theunissen, Yael Costa, Aliaksandra Radzisheuskaya, A., Anouk L. van Oosten, Fabrice Lavial, et al.. Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain. Development (Cambridge, England), Company of Biologists, 2011, 138 (22), pp.4853-4865. 10.1242/dev.068775. hal-02644461 HAL Id: hal-02644461 https://hal.inrae.fr/hal-02644461 Submitted on 28 May 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution - NonCommercial - ShareAlike| 4.0 International License DEVELOPMENT AND STEM CELLS RESEARCH ARTICLE 4853 Development 138, 4853-4865 (2011) doi:10.1242/dev.068775 © 2011. Published by The Company of Biologists Ltd Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain Thorold W. Theunissen1, Yael Costa1, Aliaksandra Radzisheuskaya1, Anouk L. van Oosten1, Fabrice Lavial2, Bertrand Pain3, L.
    [Show full text]
  • The Role of Non-Coding Rnas in Uveal Melanoma
    cancers Review The Role of Non-Coding RNAs in Uveal Melanoma Manuel Bande 1,2,*, Daniel Fernandez-Diaz 1,2, Beatriz Fernandez-Marta 1, Cristina Rodriguez-Vidal 3, Nerea Lago-Baameiro 4, Paula Silva-Rodríguez 2,5, Laura Paniagua 6, María José Blanco-Teijeiro 1,2, María Pardo 2,4 and Antonio Piñeiro 1,2 1 Department of Ophthalmology, University Hospital of Santiago de Compostela, Ramon Baltar S/N, 15706 Santiago de Compostela, Spain; [email protected] (D.F.-D.); [email protected] (B.F.-M.); [email protected] (M.J.B.-T.); [email protected] (A.P.) 2 Tumores Intraoculares en el Adulto, Instituto de Investigación Sanitaria de Santiago (IDIS), 15706 Santiago de Compostela, Spain; [email protected] (P.S.-R.); [email protected] (M.P.) 3 Department of Ophthalmology, University Hospital of Cruces, Cruces Plaza, S/N, 48903 Barakaldo, Vizcaya, Spain; [email protected] 4 Grupo Obesidómica, Instituto de Investigación Sanitaria de Santiago (IDIS), 15706 Santiago de Compostela, Spain; [email protected] 5 Fundación Pública Galega de Medicina Xenómica, Clinical University Hospital, SERGAS, 15706 Santiago de Compostela, Spain 6 Department of Ophthalmology, University Hospital of Coruña, Praza Parrote, S/N, 15006 La Coruña, Spain; [email protected] * Correspondence: [email protected]; Tel.: +34-981951756; Fax: +34-981956189 Received: 13 September 2020; Accepted: 9 October 2020; Published: 12 October 2020 Simple Summary: The development of uveal melanoma is a multifactorial and multi-step process, in which abnormal gene expression plays a key role.
    [Show full text]
  • Thoughts About SLC16A2, TSIX and XIST Gene Like Sites in the Human Genome and a Potential Role in Cellular Chromosome Counting Martina Rinčić1, Ivan Y
    Rinčić et al. Molecular Cytogenetics (2016) 9:56 DOI 10.1186/s13039-016-0271-7 HYPOTHESIS Open Access Thoughts about SLC16A2, TSIX and XIST gene like sites in the human genome and a potential role in cellular chromosome counting Martina Rinčić1, Ivan Y. Iourov2,3,4 and Thomas Liehr5* Abstract Background: Chromosome counting is a process in which cells determine somehow their intrinsic chromosome number(s). The best-studied cellular mechanism that involves chromosome counting is ‘chromosome-kissing’ and X-chromosome inactivation (XCI) mechanism. It is necessary for the well-known dosage compensation between the genders in mammals to balance the number of active X-chromosomes (Xa) with regard to diploid set of autosomes. At the onset of XCI, two X-chromosomes are coming in close proximity and pair physically by a specific segment denominated X-pairing region (Xpr) that involves the SLC16A2 gene. Results: An Ensembl BLAST search for human and mouse SLC16A2/Slc16a2 homologues revealed, that highly similar sequences can be found at almost each chromosome in the corresponding genomes. Additionally, a BLAST search for SLC16A2/TSIX/XIST (genes responsible for XCI) reveled that “SLC16A2/TSIX/XIST like sequences” cover equally all chromosomes, too. With respect to this we provide following hypotheses. Hypotheses: If a single genomic region containing the SLC16A2 gene on X-chromosome is responsible for maintaining “balanced” active copy numbers, it is possible that similar sequences or gene/s have the same function on other chromosomes (autosomes). SLC16A2 like sequences on autosomes could encompass evolutionary older, but functionally active key regions for chromosome counting in early embryogenesis.
    [Show full text]
  • XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging Mir-155-5P
    Original Article Yonsei Med J 2018 Sep;59(7):816-826 https://doi.org/10.3349/ymj.2018.59.7.816 pISSN: 0513-5796 · eISSN: 1976-2437 XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p Xiu-qing Lin, Zhi-ming Huang, Xin Chen, Fang Wu, and Wei Wu Department of Gastroenterology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Purpose: The influence of X-inactive specific transcript (XIST) and X-chromosome inactivation associated long non-coding RNAs (lncRNAs) just proximal to XIST (JPX) on hepatocellular carcinoma (HCC) remains controversial in light of previous reports, which the present study aimed to verify. Materials and Methods: The DIANA lncRNA-microRNA (miRNA) interaction database was used to explore miRNA interactions with JPX or XIST. JPX, XIST, and miR-155-5p expression levels in paired HCC specimens and adjacent normal tissue were ana- lyzed by RT-qPCR. Interaction between XIST and miR-155-5p was verified by dual luciferase reporter assay. Expression levels of miR-155-5p and its known target genes, SOX6 and PTEN, were verified by RT-qPCR and Western blot in HepG2 cells with or with- out XIST knock-in. The potential suppressive role of XIST and JPX on HCC was verified by cell functional assays and tumor for- mation assay using a xenograft model. Results: JPX and XIST expression was significantly decreased in HCC pathologic specimens, compared to adjacent tissue, which correlated with HCC progression and increased miR-155-5p expression. Dual luciferase reporter assay revealed XIST as a direct target of miR-155-5p.
    [Show full text]